• Description

This research is an attempt to understand the current situation in Uganda int erms of access to ARVs. It describes what role generic alternatives to branded ARVs have played in reducing prices and increasing access to antiretroviral therapies (ART). In addition, it reviews the laws governing pharmaceutical patients in Uganda, as well as the newly proposed Industrial Property Bill 2002 (IP Bill). Finally, the thoughts and comments of some HIV-infected patients regarding affordability of medications are also included.|Introduction, Methods, UNAIDS HIV/AIDS Drugs Initiatives, Prices and Access to Antiretrovirals, Additional Barriers to Access, Legislation Relating to Pharmaceuticals, Interviews with Patients Accessing Antiretrovirals, Limatations to the Study, Conclusions, References, Attachments

Access to Antiretroviral Therapy in Uganda: Kampala, June 2002